Explore GEN family of websites, social media experiences, blogs and more.

Unleashing ideas.
Strengthening startups.

Back to search results
    Date submitted
  • 16-Feb-2016

712 North

Abstract

712 North is a biopharmaceutical company developing drugs for patients with Alzheimer's disease and other neurodegenerative diseases. We have identified a new, proprietary molecular mechanism-of-action in a rare genetic disease of childhood blindness with the name Autosomal Dominant Optic Atrophy. We accelerate the drug development and approval process by leveraging the orphan childhood disease as fast-to-market solution.

Video

Original YouTube URL: Open

Introduction Video

Additional Questions

Investor questions have not yet been answered for this business